These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14427195)

  • 21. [POSSIBLE NON-DIABETIC EFFECTS OF SULFONYLUREA].
    BAUER G
    Medico (Eur); 1963; ():117-21. PubMed ID: 14065436
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination of DBI with a sulfonylurea in diabetic therepy.
    JONCAS F
    Appl Ther; 1962 May; 4():476-9. PubMed ID: 14452210
    [No Abstract]   [Full Text] [Related]  

  • 23. [The sulfonylureas in the treatment of the diabetic patient].
    RALLI EP
    Union Med Can; 1960 May; 89():618-26. PubMed ID: 14435982
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy and hazards of an experimental hypoglycemic sulfonylurea compound: metahexamide].
    VERNET A; RILLIET B
    Praxis; 1960 Jun; 49():620-3. PubMed ID: 13841881
    [No Abstract]   [Full Text] [Related]  

  • 25. Critical appraisal of sulfonylurea therapy of diabetes mellitus.
    BEASER SB
    JAMA; 1960 Nov; 174():1233-6. PubMed ID: 13688250
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of sulfonylurea preparations on angina pectoris and intermittent claudication in diabetic subjects.
    FABRYKANT M; ASHE BI
    N Y State J Med; 1960 Mar; 60():841-5. PubMed ID: 13821251
    [No Abstract]   [Full Text] [Related]  

  • 27. [SULFONYLUREA SENSITIVITY: ITS SIGNIFICANCE IN THE THERAPY AND PROGNOSIS OF DIABETES MELLITUS].
    ANDREEV D
    Munch Med Wochenschr; 1964 Dec; 106():2259-62. PubMed ID: 14341467
    [No Abstract]   [Full Text] [Related]  

  • 28. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of hypoglycemic drugs on the thyroid function in diabetic patients].
    CARBONNET LJ; STAFFIERI JJ; EBERHARDT DR
    An Cir (Rosario); 1958; 23(3):131-42. PubMed ID: 13606395
    [No Abstract]   [Full Text] [Related]  

  • 30. A new high potency antidiabetic sulfonylurea [N-(1-hexahydro-1-azepinyl)-N'-p-tolyl-sulfonylurea].
    DULIN WE; OSTER HL; McMAHON FG
    Proc Soc Exp Biol Med; 1961 Jun; 107():245-8. PubMed ID: 13724915
    [No Abstract]   [Full Text] [Related]  

  • 31. [PROBLEMS OF LATE FAILURE OF ORAL SULFONYLUREA THERAPY OF DIABETES].
    STRAUZENBERG SE; HALLER H; MEYER H
    Schweiz Med Wochenschr; 1965 May; 95():628-36. PubMed ID: 14305109
    [No Abstract]   [Full Text] [Related]  

  • 32. [Minimum insulin requirement and sulfonylurea therapy in diabetes mellitus].
    HOPKER W
    Klin Wochenschr; 1957 Jul; 35(13):668-72. PubMed ID: 13515033
    [No Abstract]   [Full Text] [Related]  

  • 33. Acetohexamide: comparison with other sulfonylurea compounds in the treatment of diabetes mellitus.
    BOSHELL BR; WILENSKY AS; BARRETT JC; ALMON JV
    Clin Pharmacol Ther; 1962; 3():750-7. PubMed ID: 14014164
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of oral hypoglycemic agents on thyroid function in the rat.
    TRANQUADA RE; SOLOMON DH; BROWN J; GREENE R
    Endocrinology; 1960 Sep; 67():293-7. PubMed ID: 13839184
    [No Abstract]   [Full Text] [Related]  

  • 35. Disulfiramlike actions produced by hypoglycemic sulfonylurea compounds.
    TRUITT EB; DURITZ G; MORGAN AM; PROUTY RW
    Q J Stud Alcohol; 1962 Jun; 23():197-207. PubMed ID: 13922688
    [No Abstract]   [Full Text] [Related]  

  • 36. The current status of sulphonylureas in experimental and clinical diabetes.
    TYLER DB
    J Indian Med Assoc; 1960 Dec; 35():549-51. PubMed ID: 13778866
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diabetes therapy using oral antidiabetics].
    Hasslacher C; Wahl P
    Z Allgemeinmed; 1972 Apr; 48(12):583-7. PubMed ID: 5034166
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on the problem of the protective effect of sulfonylurea derivatives on the liver].
    KNICK B; RUCKES J
    Verh Dtsch Ges Inn Med; 1959; 65():709-12. PubMed ID: 14410106
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical pharmacology and rational therapeutic use of antidiabetic drugs].
    Giraudo JR
    Rev Fac Cien Med Univ Nac Cordoba; 1979; 37(1-4):28-33. PubMed ID: 556116
    [No Abstract]   [Full Text] [Related]  

  • 40. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.